Paclitaxel Exposure and Dosage of Drug-coated Devices for the Treatment of Femoropopliteal Peripheral Artery Disease
The role of paclitaxel in the treatment of femoropopliteal peripheral arterial disease is currently ambiguous. A summary-level meta-analysis of randomised trials published in 2018 demonstrated that paclitaxel-coated devices were associated with an increased all-cause mortality in those who underwent...
Guardado en:
Autores principales: | Ceazón T Edwards, Peter A Schneider, Cindy Huynh |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Radcliffe Medical Media
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/a60b7e2b755e4b9aa004805cc787644a |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Paclitaxel- and Sirolimus-coated Balloons in Peripheral Artery Disease Treatment: Current Perspectives and Concerns
por: Masayuki Mori, et al.
Publicado: (2021) -
Role of Drug-coated Balloons in Small-vessel Coronary Artery Disease
por: Michael Megaly, et al.
Publicado: (2019) -
Anticoagulation in Peripheral Artery Disease: Are We There Yet?
por: Alessandro Cannavale, et al.
Publicado: (2020) -
The Role of Atherectomy in Peripheral Artery Disease: Current Evidence and Future Perspectives
por: Grigorios Korosoglou, et al.
Publicado: (2019) -
Adherence to Statin Therapy Drives Survival of Patients with Symptomatic Peripheral Artery Disease
por: J Dopheide, et al.
Publicado: (2020)